Axsome Therapeutics AXSM Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's operating lease liabilities (current)?
- Axsome Therapeutics (AXSM) reported operating lease liabilities (current) of $628K in Q1 2026.
- How has Axsome Therapeutics's operating lease liabilities (current) changed year-over-year?
- Axsome Therapeutics's operating lease liabilities (current) increased by 38.3% year-over-year, from $454K to $628K.
- What is the long-term trend for Axsome Therapeutics's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Axsome Therapeutics's operating lease liabilities (current) has grown at a -18.7% compound annual growth rate (CAGR), from $1.22M to $434K.
- What does operating lease liabilities (current) mean?
- The amount of lease payments due within one year.
- How do you interpret operating lease liabilities (current)?
- An increase reflects expanded physical footprint or equipment leasing, while a decrease indicates a reduction in leased assets or lease expirations.
- How does operating lease liabilities (current) compare across companies?
- Standardized under accounting rules for all companies with significant leased assets.